Risks of Less Common Cancers in Proven Mutation Carriers With Lynch Syndrome

C. Engel, M. Loeffler, V. Steinke, N. Rahner, E. Holinski-Feder, W. Dietmaier, H.K. Schackert, H. Goergens, M.V. Doeberitz, T.O. Goecke, W. Schmiegel, R. Buettner, G. Moeslein, T.G.W. Letteboer, E.G. Garcia, F.J. Hes, N. Hoogerbrugge, F.H. Menko, T.A.M. van Os, RH SijmonsA. Wagner, I Kluijt, P. Propping, H.F.A. Vasen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)4409-4415
JournalJournal of Clinical Oncology
Volume30
Issue number35
DOIs
Publication statusPublished - 2012

Cite this

Engel, C., Loeffler, M., Steinke, V., Rahner, N., Holinski-Feder, E., Dietmaier, W., ... Vasen, H. F. A. (2012). Risks of Less Common Cancers in Proven Mutation Carriers With Lynch Syndrome. Journal of Clinical Oncology, 30(35), 4409-4415. https://doi.org/10.1200/JCO.2012.43.2278